Cambridge Cognition Holdings Plc (AIM:COG)
36.50
0.00 (0.00%)
Apr 17, 2026, 3:01 PM GMT
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 16.99 million as of April 17, 2026. Its market cap has increased by 10.30% in one year.
Market Cap
16.99M
Enterprise Value
16.73M
Revenue
9.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.50
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has increased from 13.12M to 16.99M, an increase of 29.54%. That is a compound annual growth rate of 2.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 16.99M | 44.96% |
| Dec 31, 2025 | 11.72M | -24.92% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.02B |
| GSK plc | 85.13B |
| Haleon | 31.48B |
| Smith & Nephew | 10.78B |
| Inspiration Healthcare Group | 19.82M |
| Aptamer Group | 18.29M |
| Fusion Antibodies | 17.19M |
| genedrive | 15.25M |